Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Downgrades NeoGenomics to Hold

Needham Downgrades NeoGenomics to Hold

Needham analyst Mike Matson downgrades NeoGenomics (NASDAQ:NEO) from Buy to Hold.

August 22, 2022

1 minute read

Needham analyst Mike Matson downgrades NeoGenomics (NASDAQ:NEO) from Buy to Hold.

Morgan Stanley Maintains Equal-Weight on Medtronic, Lowers Price Target to $101

August 24, 8:06 AM

Morgan Stanley analyst Cecilia Furlong maintains Medtronic (NYSE:MDT) with a Equal-Weight and lowers the price target from $103 to $101.

July 25, 12:25 PM

Paycom Software (NYSE:PAYC) has observed the following analyst ratings within the last quarter:

June 6, 11:37 AM

Precigen Inc (NASDAQ:PGEN) presented data at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting from the Phase…

April 14, 4:00 PM

Within the last quarter, Greenbrier Companies (NYSE:GBX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…